Does ERENUMAB Cause Mobility decreased? 102 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Mobility decreased have been filed in association with ERENUMAB (AIMOVIG). This represents 8.6% of all adverse event reports for ERENUMAB.
102
Reports of Mobility decreased with ERENUMAB
8.6%
of all ERENUMAB reports
102
Deaths
95
Hospitalizations
How Dangerous Is Mobility decreased From ERENUMAB?
Of the 102 reports, 102 (100.0%) resulted in death, 95 (93.1%) required hospitalization, and 95 (93.1%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERENUMAB. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does ERENUMAB Cause?
Off label use (293)
Migraine (285)
Drug ineffective (280)
Gastrooesophageal reflux disease (236)
Drug intolerance (227)
Vomiting (220)
Pain (217)
Abdominal pain upper (210)
Blepharospasm (209)
Hypoaesthesia (204)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which ERENUMAB Alternatives Have Lower Mobility decreased Risk?
ERENUMAB vs ERENUMAB-AOOE
ERENUMAB vs ERENUMAB\ERENUMAB-AOOE
ERENUMAB vs ERGOCALCIFEROL
ERENUMAB vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL
ERENUMAB vs ERIBULIN